Fintel on MSN2d
Oppenheimer Downgrades RXO (RXO)
Fintel reports that on April 4, 2025, Oppenheimer downgraded their outlook for RXO (NYSE:RXO) from Outperform to Perform.
RXO Inc. price target lowered to $22 from $24 at Barclays
Barclays lowered the firm’s price target on RXO Inc. (RXO) to $22 from $24 and keeps an Overweight rating on the shares as part of a Q1 ...
Nasdaq1mon
Truist Securities Initiates Coverage of RXO (RXO) with Buy Recommendation
As of March 4, 2025, the average one-year price target for RXO is $23.14/share. The forecasts range from a low of $16.16 to a high of $27.30. The average price target represents an increase of 28. ...